| abstract |
The specification provides compositions comprising thioxanthone-based autophagy inhibitors and/or autophagy-inducing compounds for cancer therapy, pharmaceutical kits comprising these compositions, and methods of treating cancer using such compounds, compositions and kits . Additionally, the present specification provides methods of treating cancer using thioxanthone-based autophagy inhibitors and radiation therapy. |